Benefits
Intestinal protozoa in stool tests after six weeks of oregano oil
In one open-label study, 14 adults whose stools carried intestinal protozoa took 600 mg/day of emulsified oregano oil for six weeks. Entamoeba hartmanni and Endolimax nana were no longer found, Blastocystis hominis cleared in 8 of 11, and digestive symptoms improved in 7 of 11. There was no placebo group, and the paper lists Biotics Research Corporation, a company, among its author affiliations.
Antibacterial activity in laboratory cultures
A carvacrol rich oregano oil inhibited and killed Staphylococcus aureus in culture by damaging the bacterial cell membrane, at concentrations applied directly to the bacteria. In the only human infection study, adults with metabolic syndrome and minor bacterial infections took diluted oregano oil for ten days and the infections were reported reduced, but there was no placebo, no randomization and no immune measure.
Biofilm formation by urinary E. coli in laboratory tests
In a laboratory screen of 79 essential oils, carvacrol rich oregano oil inhibited biofilm formation by uropathogenic Escherichia coli at concentrations below 0.01 percent and reduced fimbriae production and swarming motility. No human study has tested oral oregano oil for urinary tract health.
Antioxidant markers in two oregano trials
In 45 healthy men, four weeks of juice fortified with an oregano extract raised urinary phenolic acids but did not change serum lipids or lipid peroxidation markers. In 24 soldiers, one 500 mg capsule of dried oregano powder taken after a hard fitness test was followed by better antioxidant and muscle damage markers than placebo over two hours. Neither study used oregano oil.
CRP and cytokine levels in small trials of purified carvacrol
These trials gave carvacrol, oregano oil's main phenol, at 1.2 mg/kg/day for two months to patients with asthma or old sulfur mustard lung injury. hs-CRP, white cells, TNF-alpha and other markers fell, mostly against each group's own baseline; one 20 person report found white cells and oxidative markers better than placebo. One team ran every trial. The carvacrol page covers them in detail.
Mechanism of action
Bacterial Cell Membrane Disruption
In laboratory work, a carvacrol rich oregano oil (84 percent carvacrol) damaged Staphylococcus aureus cell membranes and altered cell shape, with a minimum inhibitory concentration of 0.125 mg/mL and a minimum bactericidal concentration of 0.25 mg/mL; protein analysis pointed to disturbed protein synthesis and amino acid metabolism. It is not established that swallowing a softgel produces these concentrations anywhere in the body outside the gut, so this should not be read as a systemic antibiotic effect.
Biofilm Inhibition
At concentrations below those that stop growth, oregano oil and its phenols carvacrol and thymol reduced fimbriae (the structures bacteria use to attach), swarming motility and red cell clumping by uropathogenic Escherichia coli, and the bacteria were more easily killed by human whole blood in the dish. This was shown in laboratory culture only.
Oral Warmth and Irritation (TRPV3)
Carvacrol activates TRPV3, a warmth sensing channel. Applied to the human tongue in a laboratory study, it produced numbing, warmth and brief burning or stinging that faded with repeated application, which helps explain why concentrated oregano oil feels hot and irritating in the mouth.
Clinical trials
Open label study of emulsified Mediterranean oregano (Origanum vulgare) oil, 600 mg daily by mouth for six weeks, with no placebo or untreated comparison group. The author affiliations listed on the paper include Biotics Research Corporation, a company. (Force et al. 2000, Phytother Res)
14 adults whose stools tested positive for Blastocystis hominis, Entamoeba hartmanni or Endolimax nana.
Entamoeba hartmanni (4 of 4 cases), Endolimax nana (1 of 1) and Blastocystis hominis (8 of 11) were no longer found in stool after six weeks, and Blastocystis scores declined in 3 more. Gastrointestinal symptoms improved in 7 of the 11 Blastocystis positive patients. Without a comparison group, spontaneous clearance cannot be ruled out.
Non randomized clinical series: infected participants took 0.8 mL (described as 2 drops) of oregano essential oil, prepared as a 1:1 dilution in sunflower oil, twice daily for ten days; uninfected people were an untreated comparison group, and no one received a placebo or an antibiotic. The oil was 29 percent carvacrol. (Ghitea et al. 2021, Molecules)
106 adults with metabolic syndrome: 32 with staphylococcal, 51 with Escherichia coli and 2 with streptococcal minor infections, plus 20 uninfected controls.
The authors report that the minor infections were reduced after ten days, that no intestinal side effects occurred and that bioimpedance phase angle improved. The comparison with antibiotics was made against bacteria in the laboratory, not in patients.
Four week randomized double blind trial of mango orange juice (placebo) or juice enriched with 300 or 600 mg/day of total phenolics from an oregano extract, not the essential oil. (Nurmi et al. 2006, J Agric Food Chem)
45 healthy nonsmoking men.
Urinary excretion of phenolic compounds rose markedly in the higher dose group compared with placebo, but serum lipids, lipid peroxidation markers and safety measures did not change.
Randomized placebo controlled trial of one 500 mg capsule of dried, powdered Origanum vulgare (not oil) or starch placebo taken right after an army combat readiness test; no external funding. (Shirvani et al. 2022, Nutrients)
24 healthy male soldiers (12 per group), mean age 24.
At 60 and 120 minutes, creatine kinase, lactate dehydrogenase and malondialdehyde were lower and superoxide dismutase, total antioxidant capacity and glutathione peroxidase were higher than with placebo. The reported effect sizes were unusually large (d up to 9.94), and follow up lasted two hours.